U.S. Markets closed
  • S&P Futures

    3,965.50
    +3.50 (+0.09%)
     
  • Dow Futures

    33,881.00
    +24.00 (+0.07%)
     
  • Nasdaq Futures

    11,536.25
    +11.50 (+0.10%)
     
  • Russell 2000 Futures

    1,840.00
    +2.20 (+0.12%)
     
  • Crude Oil

    78.74
    +0.54 (+0.69%)
     
  • Gold

    1,766.60
    +2.90 (+0.16%)
     
  • Silver

    21.45
    +0.02 (+0.09%)
     
  • EUR/USD

    1.0353
    +0.0018 (+0.1760%)
     
  • 10-Yr Bond

    3.7480
    +0.0450 (+1.22%)
     
  • Vix

    21.89
    -0.32 (-1.44%)
     
  • GBP/USD

    1.1983
    +0.0033 (+0.2732%)
     
  • USD/JPY

    138.4680
    -0.1660 (-0.1197%)
     
  • BTC-USD

    16,904.69
    +644.80 (+3.97%)
     
  • CMC Crypto 200

    401.89
    +13.17 (+3.39%)
     
  • FTSE 100

    7,512.00
    +37.98 (+0.51%)
     
  • Nikkei 225

    27,850.21
    -177.63 (-0.63%)
     

Amarin Outlines $100M Cost Saving Plan

  • Amarin Corporation plc (NASDAQ: AMRN) announced a comprehensive cost and organizational restructuring plan to reduce operating costs by approximately $100 million over the next 12 months.

  • The restructuring will enable Amarin to maintain a positive contribution margin in the U.S. while investing in its European market launches and global expansion for Vascepa/Vazkepa.

  • The majority of the cost savings will result from a significant workforce reduction across the Company's U.S. field force and corporate positions.

  • Related: Why Amarin Shares Are Plunging After Q1 Earnings.

  • Amarin will reduce its U.S. commercial team by approximately 65% from current levels and approximately 90% of pre-pandemic and pre-generic competition levels, resulting in a core team able to support branded Vascepa revenues in the U.S.

  • These actions will result in a reduction of the total company employee base by over 40% from current levels.

  • Concurrently, Amarin appointed Tom Reilly as Chief Financial Officer, effective June 20, following the resignation of Michael Kalb.

  • Price Action: AMRN shares are up 3.35% at $1.74 during the market session on the last check Monday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.